oxaliplatin - Generic mfg.
5-fluorouracil - Generic mfg.
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
irinotecan - Generic mfg.
leucovorin calcium - Generic mfg.
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE) (clinicaltrials.gov) - Sep 24, 2026 - P2 | N=38 | Recruiting | Sponsor: Rutgers, The State University of New Jersey | Trial completion date: Aug 2026 ➔ Aug 2027 | Trial primary completion date: Aug 2026 ➔ Feb 2027 
Trial completion date • Trial primary completion date • Esophageal Cancer • Gastric Cancer • Gastroesophageal Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor • HER-2
http://clinicaltrials.gov/ct2/show/NCT05332002
 
Sep 24, 2026
 
Prev Next